CTOs on the Move

Operatrix Consulting

www.operatrix.com

 
Operatrix Consulting Inc. is a Waterdown, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.operatrix.com
  • PO Box 277 8 Nancy Ct
    Waterdown, ON CAN L0R 2H0
  • Phone: 905.690.1200

Executives

Name Title Contact Details

Similar Companies

Toby Orthopaedics

Toby Orthopaedics is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arise Health Plan

Arise Health Plan is a De Pere, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Myers Group

The Myers Group is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MSI

MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).

RRD International, LLC

Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).